NasdaqGM - Nasdaq Real Time Price USD
Inventiva S.A. (IVA)
3.7606
-0.0694
(-1.81%)
As of 11:49:59 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 4 | 4 |
| Avg. Estimate | -0.47 | -0.48 | -1.31 | -1.17 |
| Low Estimate | -0.47 | -0.48 | -1.6 | -1.8 |
| High Estimate | -0.47 | -0.48 | -1.09 | -0.53 |
| Year Ago EPS | -- | -- | -3.32 | -1.31 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 10 | 10 |
| Avg. Estimate | -- | -- | 14.86M | 20.12M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 63.4M | 90M |
| Year Ago Sales | -- | -- | 9.2M | 14.86M |
| Sales Growth (year/est) | 0.00% | -- | 61.57% | 35.36% |
Earnings History
| Currency in USD | 12/31/2024 |
|---|---|
| EPS Est. | -0.43 |
| EPS Actual | -- |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.47 | -0.48 | -1.31 | -1.17 |
| 7 Days Ago | 0 | 0 | -1.42 | -1.49 |
| 30 Days Ago | 0 | 0 | -1.53 | -1.61 |
| 60 Days Ago | 0 | 0 | -1.53 | -1.61 |
| 90 Days Ago | 0 | 0 | -1.6 | -1.61 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 3 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IVA | -- | -- | 60.61% | 10.53% |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 4/4/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/2/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/30/2025 |
| Maintains | Stifel: Buy to Buy | 11/22/2024 |
| Initiated | UBS: Neutral | 11/12/2024 |
Related Tickers
ELTX Elicio Therapeutics, Inc.
5.16
-1.15%
ADAG Adagene Inc.
1.5094
+5.55%
ABVX ABIVAX Société Anonyme
7.39
+9.18%
BIOR Biora Therapeutics, Inc.
0.2200
0.00%
AMPE Ampio Pharmaceuticals, Inc.
0.0217
-0.23%
NTHI NeOnc Technologies Holdings, Inc. Common Stock
5.70
-3.15%
IMCR Immunocore Holdings plc
29.84
+0.14%
NXOA.BE Nicox SA
0.2260
0.00%
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%